As a Research Scientist in the Heath Group, I am part of an immunotherapy team developing advanced biotechnologies to provide a New and Powerful way to treat cancer. My work is to genetically engineer the cytotoxic CD-8 (+) T-cells to be more tumor specific through the TCR seq and CRISPR/Cas9 technology.
During my Ph.D. journey, I was involved in engineering several integrated microfluidic devices for blood sample preparation, single cell manipulation and single cell proteomics study.
As future work, I would like to combine my prior training in microfluidics with a genome editing techniques to develop a microfluidic-based in vitro assay chip capable of predicting a response to immunotherapy through the multi-omics analyses.
Genome editing, Immunotherapy, Microfluidics, Single cell proteomics
Ph.D. School of Mechanical engineering, Gwangju Institute of Science and Technology, South Korea
M.S. School of Mechatronics, Gwangju Institute of Science and Technology, South Korea
B.S Department of Mechanical and Information Engineering, University of Seoul, South Korea